MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
Sritama Nath(University of North Carolina at Charlotte), Pinku Mukherjee(University of North Carolina at Charlotte)
Cited by 174
Related Papers
Overcoming Immunological Resistance Enhances the Efficacy of a Novel anti-tMUC1 CAR T Cell Treatment Against Pancreatic Ductal Adenocarcinoma
|bioRxiv (Cold Spring Harbor Laboratory)|2019|22
Mucin-1–Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host
|Journal of Immunotherapy|2024|15
Molecular crosstalk between MUC1 and STAT3 influences the anti-proliferative effect of Napabucasin in epithelial cancers
|Scientific Reports|2024|7
Transcriptional regulation of genes associated with drug resistance and growth of pancreatic cancer cells by mucin 1
|NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro)|2013|1